247 related articles for article (PubMed ID: 6497506)
1. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
[TBL] [Abstract][Full Text] [Related]
2. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
3. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
4. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
5. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
6. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
Tarayre JP; Lauressergues H; Fauran F
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
[TBL] [Abstract][Full Text] [Related]
8. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
[TBL] [Abstract][Full Text] [Related]
11. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
12. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
Tasaka K; Akagi M; Izushi K; Mio M
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.
Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ
Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic activities of the beta-adrenoceptor stimulant formoterol (BD 40A).
Tomioka K; Yamada T; Ida H
Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):279-92. PubMed ID: 6168241
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
Miller P; James GW
Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
Spicer BA; Ross JW; Smith H
Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological studies on oxatomide (KW-4354): (1) Effect on passive cutaneous anaphylaxis (PCA)].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):251-60. PubMed ID: 6130032
[TBL] [Abstract][Full Text] [Related]
19. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
[TBL] [Abstract][Full Text] [Related]
20. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
Casey FB; Abboa-Offei BE; Marretta J
J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
